About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 290 blog entries.

Americans Support Seniors’ Access to Pharmacist-Provided Care: Help Congress Pass H.R. 3164 / S. 2426 This Year

2026-10-29T12:43:29-04:00Categories: Memo|Tags: |

To: NACDS Members
From: Steven C. Anderson, FASAE, CAE, IOM
President & Chief Executive Officer
Date: October 23, 2026

Congress has a real opportunity in the coming weeks to give Medicare beneficiaries access to pharmacist-provided care that their own states already allow. I am writing to update you on where the Main Street Pharmacy Access Act / Ensuring Community Access to Pharmacist Services Act (H.R. 3164 / S. 2426) stands, to share new resources that show how strongly Americans support it, and to ask for your help making sure lawmakers hear from the people they represent.

This bipartisan legislation, led in the House by Reps. Adrian Smith (R-NE), Brad Schneider (D-IL), Diana Harshbarger (R-TN), and Doris Matsui (D-CA) and in the Senate by Sens. John Thune (R-SD) and Mark Warner (D-VA), would enable seniors in Medicare to receive pharmacist-provided testing and treatment for certain common respiratory conditions, such as flu and strep throat, in states that already authorize pharmacists to provide these services. Many other Americans can already access this care, but seniors miss out because pharmacists are overlooked as eligible healthcare providers in the Social Security Act. The bill is a pragmatic fix that would improve access to timely care, ease pressure on emergency rooms, urgent care clinics, and physician offices, and help prevent avoidable and costly hospitalizations.

The legislation has built steady momentum this year. The House Ways and Means Committee advanced H.R. 3164 by a voice vote in May, and the House Energy and Commerce Subcommittee on Health held a hearing on the bill on September 15. In total, 176 members of Congress, almost one-third of both chambers, have cosponsored it, and more than 170 organizations support it, including senior and rural advocacy groups, patient advocacy organizations, pharmacists, and health systems. We are grateful to every lawmaker who has helped bring this legislation so far.

Our goal now is passage before the end of this Congress. Government funding runs through December 11, and the weeks following the November 3 elections will bring funding and possibly other legislative items to the forefront. H.R. 3164 / S. 2426 is well-positioned for inclusion in [ READ MORE ]

A Message from NACDS’ Incoming President and CEO, Michael R. Wysong

2026-10-15T09:34:57-04:00Categories: In Case You Missed It|Tags: |

It’s a pivotal moment for pharmacy, and NACDS will continue to shape its future, with our members leading the way.

NACDS Names Michael R. Wysong Next President and CEO

2026-10-06T11:21:54-04:00Categories: Press Release|Tags: |

Elected by the NACDS Board of Directors to succeed Steven C. Anderson, Wysong will build on the Association’s success and momentum, and execute its new member-driven strategic framework for the future of pharmacy and retail, and for delivering membership value.

CARE Pharmacies CEO and past NACDS chair brings broad industry knowledge, strong relationships, and energetic advocacy to the crucial work of meeting Americans’ needs through accessible and trusted health and wellness destinations and their supplier partners.

Pharmacy Coalition Commends CMS RFI on Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards

2026-09-29T15:03:21-04:00Categories: Press Release|Tags: , , , , |

A national coalition of pharmacy groups today issued the following statement on the Centers for Medicare & Medicaid Services’ (CMS) RFI on Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards — which is part of the implementation of pharmacy benefit manager (PBM) reforms enacted in February 2026:

Our organizations welcome CMS’s release of a thoughtful and comprehensive Request for Information (RFI) to inform the development and implementation of standards for reasonable and relevant Medicare Part D pharmacy contract terms and conditions. The RFI represents an important step toward translating Congress’s bipartisan reforms into meaningful protections for pharmacies and Medicare beneficiaries. Through detailed questions addressing the contracting practices and operational issues that matter most to pharmacies and the patients they serve, CMS has demonstrated its commitment to building a robust factual record and developing workable, transparent, and enforceable standards.

We commend CMS for engaging constructively with stakeholders throughout this process and look forward to providing a comprehensive response to the RFI. Our coalition remains committed to working collaboratively with CMS to ensure these reforms strengthen pharmacy access and choice for Medicare beneficiaries.

Go to Top